ライフサイエンスコーパス: tumor-infiltrating lymphocyte

1 ociated with a dramatic increase of NKG2D(+)-tumor infiltrating lymphocytes.

2 n association with elevated levels of Type-1 tumor-infiltrating lymphocytes.

3 or microenvironment that rapidly inactivates tumor-infiltrating lymphocytes.

4 ors in restricting TCR-mediated signaling in tumor-infiltrating lymphocytes.

5 H)2-skewed cytokine profile within blood and tumor-infiltrating lymphocytes.

6 Mechanisms were evaluated by analysis of tumor-infiltrating lymphocytes.

7 13 following adoptive transfer of autologous tumor-infiltrating lymphocytes.

8 carcinoma (RCC) tumors of the kidney and RCC tumor-infiltrating lymphocytes.

9 ated gene expression with protein status and tumor-infiltrating lymphocytes.

10 ls in the spleen and to generate E7-specific tumor-infiltrating lymphocytes.

11 8+ T cells and was associated with increased tumor-infiltrating lymphocytes.

12 n, especially tumor-induced angiogenesis and tumor-infiltrating lymphocytes.

13 fic CD8 responses detectable in PBMCs and in tumor-infiltrating lymphocytes.

14 haracterized chief cells, oxyphil cells, and tumor-infiltrating lymphocytes.

15 tory cells and decreased abundance of CD8(+) tumor-infiltrating lymphocytes.

16 ell line is efficiently lysed by the ex vivo tumor-infiltrating lymphocytes, all of the recurrent tum

17 IHC was used to determine the presence of tumor infiltrating lymphocytes and antigen-presenting ce

18 se the tumor uptake by approximately 40% for tumor-infiltrating lymphocytes and by approximately 60%

19 ing of freshly isolated CD8(+)/CD103(+) lung tumor-infiltrating lymphocytes and CD103(+) tumor-specif

20 ry CD8 T cells, as well as melanoma-reactive tumor-infiltrating lymphocytes and CD8 T cell clones.

21 sociated tumor cells increased the number of tumor-infiltrating lymphocytes and enhanced the survival

22 n of ex vivo-activated, melanoma Ag-specific tumor-infiltrating lymphocytes and high dose IL-2 result

23 137 mAbs and showed CD137 internalization in tumor-infiltrating lymphocytes and in activated human T

24 o ex vivo phenotypes of T and NK cells among tumor-infiltrating lymphocytes and in peripheral blood f

25 s corresponded with significant increases in tumor-infiltrating lymphocytes and increased expression

26 33 suggest its involvement in trafficking of tumor-infiltrating lymphocytes and indicate that STRL33

27 these DLBCLs include significant numbers of tumor-infiltrating lymphocytes and interdigitating dendr

28 umbers of morphologically distinct CD2+/CD3+ tumor-infiltrating lymphocytes and interdigitating S100+

29 In tumor-infiltrating lymphocytes and lymph node lymphocyte

30 ults suggest that IL-2 and -15 elaborated by tumor-infiltrating lymphocytes and macrophages may affec

31 gen MART-1/melan A is frequently observed in tumor-infiltrating lymphocytes and may be readily elicit

32 condary endpoints included the generation of tumor-infiltrating lymphocytes and modulation of immune

33 the presence of the Fas(CD95)-R molecule on tumor-infiltrating lymphocytes and on matched peripheral

34 e observed in the non-small cell lung cancer tumor-infiltrating lymphocytes and ovarian cancer tumor-

35 heckpoint inhibitors increases the number of tumor-infiltrating lymphocytes and overall survival afte

36 re, we detect neoepitope-specific T cells in tumor-infiltrating lymphocytes and peripheral blood from

37 nt exist based on the presence or absence of tumor-infiltrating lymphocytes and programmed death-liga

38 Stromal tumor-infiltrating lymphocytes and their association wit

39 and activity, attenuated Foxp3 expression in tumor-infiltrating lymphocytes, and decreased tumor burd

40 X40 on CD4(+) FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, and increased the antitu

41 ll type, presence of melanin, nuclear grade, tumor-infiltrating lymphocytes, and necrosis.

42 eg) that coexpress CD4 and CD25 in the PBLs, tumor-infiltrating lymphocytes, and regional lymph node

43 than 0, growth phase, thickness, ulceration, tumor-infiltrating lymphocytes, and sex were associated

44 Tumor-infiltrating lymphocytes appear to be a predictor

45 Parathyroid tumor infiltrating lymphocytes are T cells by immunophen

46 However, tumor-infiltrating lymphocytes are defective in effector

47 In malignant melanoma, tumor-infiltrating lymphocytes are frequently reactive w

48 Tumor-infiltrating lymphocytes are key mediators of tumo

49 gene product that was recognized by the bulk tumor-infiltrating lymphocytes as well as a dominant T c

50 The presence of tumor-infiltrating lymphocytes at diagnosis is reported

51 g Ag104, these cells made up the majority of tumor-infiltrating lymphocytes at the late stage of tumo

52 leukin (IL)-2-based therapy (five patients), tumor-infiltrating lymphocyte-based therapy plus IL-2 (n

53 mor exhibit no gross defect in the number of tumor-infiltrating lymphocytes but have exaggerated angi

54 This correlated with decreased number of tumor-infiltrating lymphocytes but with elevated levels

55 rity of melanoma patients analyzed and among tumor-infiltrating lymphocytes, but not in healthy donor

56 0: 331-340, respectively, were recognized by tumor-infiltrating lymphocyte clone M37 in an HLA-A2-res

57 Tumor-infiltrating lymphocytes coexpressed PD-1 with the

58 ich were associated with increased levels of tumor-infiltrating lymphocytes compared with HPV-driven

59 nt increase in the Fas(CD95)-R expression on tumor-infiltrating lymphocytes compared with matched pat

60 NKG2D levels were augmented more in tumor-infiltrating lymphocytes compared with splenocytes

61 imilar to those found in human melanoma, and tumor-infiltrating lymphocytes could be cultured from th

62 s are currently testing strategies to infuse tumor-infiltrating lymphocytes, CTLs, Th cells, and Treg

63 ty for tumor antigens that were derived from tumor-infiltrating lymphocytes cultured for limited time

64 autologous tumor-reactive, rapidly expanded tumor infiltrating lymphocyte cultures and high-dose IL-

65 Finally, nonmelanoma-reactive tumor-infiltrating lymphocyte cultures developed antimel

66 In contrast, g9-209-reactive tumor-infiltrating lymphocyte cultures generally reacted

67 Interestingly, 12 of 20 tumor-infiltrating lymphocyte cultures recognized F001TU

68 noma lines (F001TU-3 and -4) and 20 separate tumor-infiltrating lymphocyte cultures were generated fr

69 Analysis of tumor-infiltrating lymphocytes demonstrated that CB T ce

70 ication of Tax+ tumor cells and nonmalignant tumor-infiltrating lymphocytes demonstrated that each of

71 patient subsequently received treatment with tumor-infiltrating lymphocytes derived from gene-modifie

72 tion, FACS-based enumeration of intracranial tumor-infiltrating lymphocytes directly correlated with

73 r immunity was accompanied by an increase of tumor-infiltrating lymphocytes displaying low PD-1 expre

74 and induced type-1 polarization in CD8+CD28- tumor-infiltrating lymphocytes ex vivo.

75 phocyte fronts, whereas the majority of CD8+ tumor-infiltrating lymphocytes express high levels of PD

76 Treg in tumor-infiltrating lymphocytes expressed ICOS (mean fluo

77 We have further demonstrated that tumor-infiltrating lymphocytes expressed TIGIT and that

78 umor-specific CTL clone was established from tumor-infiltrating lymphocytes from a regressing pulmona

79 Analysis of tumor-infiltrating lymphocytes from Bach2-deficient mice

80 we show that CD8+ T cells, isolated from the tumor-infiltrating lymphocytes from human melanoma, synt

81 study, we show that engagement of CTLA-4 on tumor-infiltrating lymphocytes from low-dose melphalan (

82 termined on CD4+CD25high T cells in PBMC and tumor-infiltrating lymphocytes from melanoma patients (n

83 4(+) cells that are otherwise observed among tumor-infiltrating lymphocytes from mice treated with IL

84 L-PAM-induced acquisition of the ability of tumor-infiltrating lymphocytes from MOPC-315 tumor beare

85 biomarkers in circulating blood cells and in tumor-infiltrating lymphocytes from patients with resect

86 taneous T cell lymphoma and the isolation of tumor-infiltrating lymphocytes from primary squamous cel

87 from peripheral blood mononuclear cells and tumor-infiltrating lymphocytes from stage I-IV HLA-A(*)0

88 Likewise, PD1 and CD137 were induced on tumor-infiltrating lymphocytes from surgically excised h

89 h lymphocytes harvested from treated tumors (tumor-infiltrating lymphocytes) generated significant in

90 level in the resected tumor samples used for tumor-infiltrating lymphocyte generation.

91 ressed in splenocytes, activated PBL, CD8(+) tumor infiltrating lymphocytes, granulocytes, and monocy

92 her T-cell receptor (TCR)-CD3 components, in tumor-infiltrating lymphocytes, human immunodeficiency v

93 cognized by tumor reactive CTLs derived from tumor infiltrating lymphocytes in the context of HLA-A31

94 sed survival with the presence or absence of tumor-infiltrating lymphocytes in a given patient.

95 hocytes in rats; (b) interleukin 2-activated tumor-infiltrating lymphocytes in humans; (c) nonactivat

96 Patients with increased numbers of tumor-infiltrating lymphocytes in primary colon tumors a

97 Approaches to enhance tumor-infiltrating lymphocytes in the tumor bed may subs

98 hanges were correlated with Ki-67 and CD8(+) tumor-infiltrating lymphocytes in the tumor biopsies tak

99 urther validation of the clinical utility of tumor-infiltrating lymphocytes in this context is warran

100 The presence of tumor-infiltrating lymphocytes in triple-negative breast

101 ssociated with significantly lower levels of tumor-infiltrating lymphocytes in triple-negative breast

102 Recent clinical trials of ex vivo-expanded tumor-infiltrating lymphocytes indicated that differenti

103 + T cells and natural killer (NK) cells from tumor-infiltrating lymphocytes indicated that NK cells w

104 Systematic interrogation of tumor-infiltrating lymphocytes is key to the development

105 cal responses to adoptive immunotherapy with tumor-infiltrating lymphocytes isolated from human melan

106 tumorigenic than the parental cell line, and tumor-infiltrating lymphocytes isolated from these tumor

107 e log-fold increase in stimulation of a CD4+ tumor-infiltrating lymphocyte line.

108 ocking anti-CTLA-4 mAb) resulted in enhanced tumor-infiltrating lymphocyte-mediated anti-MOPC-315 cyt

109 al suppressive activity that may account for tumor-infiltrating lymphocyte-mediated immune evasion by

110 gainst the transcription factor SOX10, using tumor-infiltrating lymphocytes obtained from a patient w

111 T-cell response against mutant KRAS G12D in tumor-infiltrating lymphocytes obtained from a patient w

112 variation in a clinical setting, we screened tumor-infiltrating lymphocytes of an HLA-A*02:06 melanom

113 ope of CD8+ T cells, commonly recovered from tumor-infiltrating lymphocytes of HLA-A2.1+ melanoma pat

114 lls were present in the peripheral blood and tumor-infiltrating lymphocytes of lymphoma patients, cou

115 s also found in the draining lymph nodes and tumor-infiltrating lymphocytes of OSCC patients with ear

116 Moreover, CCR6(+) Treg cells isolated from tumor-infiltrating lymphocytes or draining lymph nodes m

117 le CD4(+) T-cell clones isolated either from tumor-infiltrating lymphocytes or peripheral blood monon

118 01) but not with cell type, mitotic figures, tumor-infiltrating lymphocytes, or PAS-positive patterns

119 munogenic response consistent with increased tumor infiltrating lymphocytes, particularly within meta

120 system resulting in more IFN-gamma-producing tumor-infiltrating lymphocytes per tumor when compared w

121 tor function on human memory CD8 T cells and tumor-infiltrating lymphocytes reactive against melanoma

122 CD8(+)tumor-infiltrating lymphocytes reactive to clonal neoant

123 ration into treated lesions was observed and tumor-infiltrating lymphocyte reactivity was enhanced in

124 Adoptive immunotherapy using tumor-infiltrating lymphocytes represents an effective c

125 melanoma-reactive T cell cloid derived from tumor infiltrating lymphocytes resulted in the isolation

126 ent in the in vitro-expanded and transferred tumor-infiltrating lymphocyte samples and certain T cell

127 alpha-beta paired T-cell receptors (TCRs) of tumor-infiltrating lymphocytes shared between multiple p

128 Expanded tumor-infiltrating lymphocytes showed TCR repertoire ske

129 evels of cytokine release by MART-1-specific tumor-infiltrating lymphocytes than control DCs transduc

130 Tumor-infiltrating lymphocytes that accomplish tumor rej

131 apy as evidenced by an active recruitment of tumor-infiltrating lymphocytes that are capable of lysin

132 -1:28 engineering reinstated Th1 function in tumor-infiltrating lymphocytes that had been functionall

133 ls of chemotherapy or radiation can increase tumor-infiltrating lymphocytes that overcome resistance

134 ly, irradiated mice had increased numbers of tumor-infiltrating lymphocytes that secreted IFN-gamma a

135 oximately 1.11x10(11) HLA-C*08:02-restricted tumor-infiltrating lymphocytes that were composed of fou

136 cytic lineage-specific antigen recognized by tumor-infiltrating lymphocytes, the adoptive transfer of

137 Melanoma prognosis is dictated by tumor-infiltrating lymphocytes, the migratory and functi

138 Twenty separate tumor infiltrating lymphocyte (TIL) bulk cultures and a

139 hat the same autologous tumor-cytolytic CD8+ tumor infiltrating lymphocyte (TIL) clone accumulated in

140 cells had corresponding effects on local DN tumor infiltrating lymphocyte (TIL) levels and inversely

141 Tumor infiltrating lymphocytes (TIL) can be isolated fro

142 es were screened with four CTLs derived from tumor infiltrating lymphocytes (TIL) that were able to r

143 ymphodepletion before infusion of autologous tumor infiltrating lymphocytes (TIL), objective response

144 ntigen tyrosinase was isolated from a CD4(+) tumor-infiltrating lymphocyte (TIL 1383I) and introduced

145 nin, which was shown to be recognized by the tumor-infiltrating lymphocyte (TIL) 1290, a HLA-A24 rest

146 4 MART-1:27-35 (MART-1) melanoma Ag-reactive tumor-infiltrating lymphocyte (TIL) clones from the tumo

147 onstrated the role of CD103 integrin on lung tumor-infiltrating lymphocyte (TIL) clones in promoting

148 h presence of mitoses (1.8 [1.0-3.3]), lower tumor-infiltrating lymphocyte (TIL) grade (nonbrisk, 0.5

149 a unique melanoma Ag recognized by a CD4(+) tumor-infiltrating lymphocyte (TIL) line.

150 mmune checkpoint, both of which can increase tumor-infiltrating lymphocyte (TIL) numbers.

151 Finally, studies conducted on tumor-infiltrating lymphocyte (TIL) samples that were ad

152 analyzing the pattern of gene expression of tumor-infiltrating lymphocyte (TIL), which can minimize

153 eukocyte antigen (HLA)-DR1-restricted CD4(+) tumor-infiltrating lymphocyte (TIL)1363 using a genetic

154 is of the recognition of melanoma Ags by the tumor-infiltrating lymphocytes (TIL) 1790, isolated from

155 Adoptive immunotherapy with tumor-infiltrating lymphocytes (TIL) and IL-2 appears to

156 We isolated tumor-infiltrating lymphocytes (TIL) and intra-hepatic l

157 A, and CD4 mRNAs and their relationship with tumor-infiltrating lymphocytes (TIL) and PD-L1 IHC expre

158 Adoptive immunotherapy with tumor-infiltrating lymphocytes (TIL) and systemic low do

159 combined treatment exhibited an increase in tumor-infiltrating lymphocytes (TIL) and T cells, as rev

160 CD8(+) tumor-infiltrating lymphocytes (TIL) are defective in cy

161 e TCR repertoires of Tregs and Tconvs within tumor-infiltrating lymphocytes (TIL) are largely distinc

162 Tumor-infiltrating lymphocytes (TIL) are potent mediator

163 CD8+ tumor-infiltrating lymphocytes (TIL) are severely defici

164 Tumor-infiltrating lymphocytes (TIL) are well known to b

165 naturally occurring and genetically modified tumor-infiltrating lymphocytes (TIL) by inhibitory recep

166 Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor re

167 ternatively, adoptive transfer of autologous tumor-infiltrating lymphocytes (TIL) can mediate tumor r

168 (+) T cells from melanoma patients' PBMC and tumor-infiltrating lymphocytes (TIL) capture melanoma Ag

169 Exhaustion of tumor-infiltrating lymphocytes (TIL) correlated with exp

170 Two thirds of CD8(+) tumor-infiltrating lymphocytes (TIL) expressed PD-1, whe

171 ere, we investigated the prognostic value of tumor-infiltrating lymphocytes (TIL) expressing CD3, Fox

172 results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, I

173 Recent studies have found that tumor-infiltrating lymphocytes (TIL) expressing PD-1 can

174 In this study, we characterized murine tumor-infiltrating lymphocytes (TIL) for activation stat

175 equencing-based approach to demonstrate that tumor-infiltrating lymphocytes (TIL) from a patient with

176 The expansion of autologous tumor cells and tumor-infiltrating lymphocytes (TIL) from fine needle as

177 Tumor-infiltrating lymphocytes (TIL) from melanoma patie

178 Using flow cytometry, we evaluated tumor-infiltrating lymphocytes (TIL) from patients under

179 ic changes in the tumor microenvironment and tumor-infiltrating lymphocytes (TIL) in a B-RafV600E/Pte

180 ce of adding TBI to the adoptive transfer of tumor-infiltrating lymphocytes (TIL) in a randomized fas

181 Recognition of the melanoma Ag gp100 by tumor-infiltrating lymphocytes (TIL) in vitro has been c

182 The presence of tumor-infiltrating lymphocytes (TIL) is a favorable prog

183 Tumor-infiltrating lymphocytes (TIL) isolated from melan

184 CD8(+) tumor-infiltrating lymphocytes (TIL) lack in vivo and in

185 ss I-restricted CD4(+) T cells obtained from tumor-infiltrating lymphocytes (TIL) of a metastatic mel

186 Adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) results in complete

187 colorectal cancers have a higher density of tumor-infiltrating lymphocytes (TIL) than other colorect

188 tumor, but it has been difficult to identify tumor-infiltrating lymphocytes (TIL) that show in vitro

189 Tumor-infiltrating lymphocytes (TIL) were evident after,

190 sms of self-tolerance often result in CD8(+) tumor-infiltrating lymphocytes (TIL) with a hypofunction

191 icularly the adoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TIL), is a very promisin

192 ions and correspondingly expanded autologous tumor-infiltrating lymphocytes (TIL), we show how MHC cl

193 s and with an augmented population of CD8(+) tumor-infiltrating lymphocytes (TIL).

194 mononuclear cells (PBMC), ascitic fluid, and tumor-infiltrating lymphocytes (TIL).

195 ollowing the adoptive transfer of autologous tumor-infiltrating lymphocytes (TIL).

196 he association of HHLA2 with the presence of tumor infiltrating lymphocytes (TILs) and five-year-even

197 Tumor infiltrating lymphocytes (TILs) derived from tumor

198 Tumor infiltrating lymphocytes (TILs) have been associat

199 s I-restricted CD4+ T cell isolated from the tumor infiltrating lymphocytes (TILs) of a patient with

200 ha- and interleukin (IL)-17-producing CD4(+) tumor-infiltrating lymphocytes (TILs) and aggressive dis

201 autoimmune diseases, their prevalence among tumor-infiltrating lymphocytes (TILs) and function in hu

202 Adoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocytes (TILs) and high-dose inte

203 tive (TN) breast cancers (BCs), we evaluated tumor-infiltrating lymphocytes (TILs) and immunologicall

204 Evaluation of tumor-infiltrating lymphocytes (TILs) and PD-1 and PD-L1

205 ation and single-cell RNA profiles of CD8(+) tumor-infiltrating lymphocytes (TILs) and used genetic p

206 Accumulating evidence indicates that tumor-infiltrating lymphocytes (TILs) are associated wit

207 Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated wit

208 Tumor-infiltrating lymphocytes (TILs) are considered a m

209 It is well known that CD8(+) tumor-infiltrating lymphocytes (TILs) are correlated wit

210 Tumor-infiltrating lymphocytes (TILs) are important prog

211 umors; however, the antigen specificities of tumor-infiltrating lymphocytes (TILs) are not well under

212 Adoptive cell transfer of tumor-infiltrating lymphocytes (TILs) can mediate cancer

213 Adoptive transfer of tumor-infiltrating lymphocytes (TILs) can mediate regres

214 Tumor-infiltrating lymphocytes (TILs) derived from tumor

215 tive immunotherapy with autologous antitumor tumor-infiltrating lymphocytes (TILs) following nonmyelo

216 Long-term follow-up of patients receiving tumor-infiltrating lymphocytes (TILs) for metastatic mel

217 immunologic screening, we demonstrated that tumor-infiltrating lymphocytes (TILs) from 9 out of 10 p

218 tified a unique ILC population that inhibits tumor-infiltrating lymphocytes (TILs) from high-grade se

219 ific (TA-specific) CD8(+) T cells and CD8(+) tumor-infiltrating lymphocytes (TILs) from patients with

220 the T-cell receptor-associated zeta chain in tumor-infiltrating lymphocytes (TILs) has been proposed

221 ion of ex vivo cultured, naturally occurring tumor-infiltrating lymphocytes (TILs) has been shown to

222 lls (NK), T-cells, dendritic cells (DC), and tumor-infiltrating lymphocytes (TILs) have been document

223 uced immunity, the phenotype and function of tumor-infiltrating lymphocytes (TILs) in 9Lneo and 9LmIL

224 Tregs represented a large proportion of the tumor-infiltrating lymphocytes (TILs) in claudin-low tum

225 The phenotype and cell cycle status of tumor-infiltrating lymphocytes (TILs) in HCC were analyz

226 lobulin mucin (Tim) 3 is expressed on CD8(+) tumor-infiltrating lymphocytes (TILs) in mice bearing so

227 o received adoptively transferred autologous tumor-infiltrating lymphocytes (TILs) in phase 2 clinica

228 the role of different subsets of regulatory tumor-infiltrating lymphocytes (TILs) in the immunopatho

229 Although the presence of tumor-infiltrating lymphocytes (TILs) indicates an endog

230 Importance: The presence of tumor-infiltrating lymphocytes (TILs) is a favorable pro

231 The presence of tumor-infiltrating lymphocytes (TILs) is associated with

232 flammation in which the effector function of tumor-infiltrating lymphocytes (TILs) is severely impair

233 We determined how CD8(+) melanoma tumor-infiltrating lymphocytes (TILs) isolated from two

234 Tumor-infiltrating lymphocytes (TILs) obtained from the

235 tumor-specific CD4(+) Treg cell clones from tumor-infiltrating lymphocytes (TILs) of cancer patients

236 c CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients

237 Tumor-infiltrating lymphocytes (TILs) possessed higher V

238 studies suggest more favorable survival with tumor-infiltrating lymphocytes (TILs) present in primary

239 However, the evaluation of tumor-infiltrating lymphocytes (TILs) relies on histopat

240 Adoptive cell therapy with tumor-infiltrating lymphocytes (TILs) represents an effe

241 ession and chromatin accessibility in CD8(+) tumor-infiltrating lymphocytes (TILs) that recognize a m

242 In a recent report,, the presence of CD3+ tumor-infiltrating lymphocytes (TILs) was found to corre

243 Tumor-infiltrating lymphocytes (TILs) were scored in hem

244 Percentage of tumor cells and tumor-infiltrating lymphocytes (TILs) with PD-L1 express

245 ent survival, an immune response linked with tumor-infiltrating lymphocytes (TILs), and a repressed C

246 infiltrating immune cells (IC), abundance of tumor-infiltrating lymphocytes (TILs), and expression of

247 transfer from melanoma to T cells, including tumor-infiltrating lymphocytes (TILs), and subsequently

248 ed from peripheral blood lymphocytes (PBLs), tumor-infiltrating lymphocytes (TILs), and tumor-associa

249 mphoid progenitor cells and cytotoxic CD8(+) tumor-infiltrating lymphocytes (TILs), leading to a majo

250 CRC for the presence of functionally active tumor-infiltrating lymphocytes (TILs), the tumor specifi

251 of TCRbeta(+) CD8(+) IL-17(+) T cells among tumor-infiltrating lymphocytes (TILs).

252 s associated with the absence or presence of tumor-infiltrating lymphocytes (TILs).

253 ed MART-1(27-35) peptide-stimulated PBLs and tumor-infiltrating lymphocytes (TILs).

254 Singer et al. characterize dysfunctional tumor infiltrating lymphocytes to reveal a role for zinc

255 ssel endothelial cells, and 2) acting on the tumor-infiltrating lymphocytes to indirectly alter endot

256 h AdVMART1 stimulated MART-1(27-35)-specific tumor-infiltrating lymphocytes to synthesize IFN-gamma.

257 le MEK inhibition can promote recruitment of tumor-infiltrating lymphocytes to the tumor, here we sho

258 was widespread RAR alpha immunoreactivity in tumor-infiltrating lymphocytes, vascular endothelial cel

259 The number of tumor-infiltrating lymphocytes was also reduced in LKB1-

260 ly, traditional histologic identification of tumor-infiltrating lymphocytes was not a significant ind

261 The upregulation of IL-17-secreting CD4(+) tumor-infiltrating lymphocytes was substantiated at the

262 Activated and proliferating tumor-infiltrating lymphocytes were evident in these mic

263 To characterize the putative T-pro cells, tumor-infiltrating lymphocytes were isolated from normal

264 Finally, tumor-reactive in vitro expanded tumor infiltrating lymphocytes, which are used clinicall

265 The TCR alpha- and beta-chain genes from a tumor-infiltrating lymphocyte, which recognized the tyro

266 h model, GSK-3i inhibited PD-1 expression on tumor-infiltrating lymphocytes, while increasing Tbx21 (

267 The growth of large numbers of tumor-infiltrating lymphocytes with in vitro anti-cancer

268 In addition, tumor-infiltrating lymphocytes with reactivity against n